Evidence map›Paper›PMID 21458920›Full record

ArticlePain2011

Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia.

Ruben Gomez, Elaine D Por, Kelly A Berg, William P Clarke, Marc J Glucksman, Nathaniel A Jeske

Open access · greenAbstract read
In one paragraph

Article in Pain, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Neurolysin Knockout Mice in a Diet-Induced Obesity Model.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Somatosensory scaffolding structures.Frontiers in molecular neuroscience · 2012
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ruben GomezDepartment of Oral and Maxillofacial Surgery, University of Texas Health Science Center of San Antonio, TX, USA Department of Pharmacology, University of Texas Health Science Center of San Antonio, TX, USA Center for Biomedical Neuroscience, University of Texas Health Science Center of San Antonio, TX, USA Department of Biochemistry and Molecular Biology and Midwest Proteome Center, Rosalind Franklin University of Medicine and Science/Chicago Medical School, North Chicago, IL, USA.
Elaine D Por
Kelly A Berg
William P Clarke
Marc J Glucksman
Nathaniel A Jeske
The University of Texas Health Science Center at San Antonio · USRosalind Franklin University of Medicine and Science · US

Funding

Neural EP24.15- A Model for Neuropeptidase FunctionR01NS039892 · NINDS · ROSALIND FRANKLIN UNIV OF MEDICINE &SCI · PI GLUCKSMAN, MARC J · 2000 to 2009
$2.7M
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATIONR01NS061884 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JESKE, NATHANIEL AARON · 2008 to 2011
$1.3M
Estrogen regulation of inflammatory mediator signalingR01NS055835 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARKE, WILLIAM P · 2008 to 2011
$1.3M
Regulation of opioid receptor function in trigeminal ganglionR01DA024865 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARKE, WILLIAM P · 2009 to 2012
$1.3M
Delta-kappa opioid receptor interactions: Ligand-dependent effectsR21DA026619 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BERG, KELLY ANN · 2009 to 2010
$396k
NIDA NIH HHS DA26619NIDA NIH HHS R01 DA024865NIDA NIH HHS R21 DA026619NINDS NIH HHS NS039892NINDS NIH HHS NS061884NINDS NIH HHS NS55835NINDS NIH HHS R01 NS039892NINDS NIH HHS R01 NS055835NINDS NIH HHS R01 NS061884
6 · The paper itself

Abstract

The neuropeptide bradykinin (BK) sensitizes nociceptor activation following its release in response to inflammatory injury. Thereafter, the bioactivity of bradykinin is controlled by the enzymatic activities of circulating peptidases. One such enzyme, the metalloendopeptidase EC3.4.24.15 (EP24.15), is co-expressed with bradykinin receptors in primary afferent neurons. In this study, using approaches encompassing pharmacology, biochemistry, cell biology, and behavioral animal models, we identified a crucial role for EP24.15 and the closely related EP24.16 in modulating bradykinin-mediated hyperalgesia. Pharmacological analyses indicated that EP24.15 and EP24.16 inhibition significantly enhances bradykinin type-2 receptor activation by bradykinin in primary trigeminal ganglia cultures. In addition, bradykinin-induced sensitization of TRPV1 activation was increased in the presence of the EP24.15/16 inhibitor JA-2. Furthermore, behavioral analyses illustrated a significant dose-response relationship between JA-2 and bradykinin-mediated thermal hyperalgesia. These results indicate an important physiological role for the metallopeptidases EP24.15 and EP24.16 in regulating bradykinin-mediated sensitization of primary afferent nociceptors.

Indexed as

AnimalsBradykininCalciumCells, CulturedDisease Models, AnimalDose-Response Relationship, DrugDrug SynergismEnzyme InhibitorsGene Expression Regulation, EnzymologicHyperalgesiaInositol PhosphatesMaleMetalloproteasesOligopeptidesRatsRats, Sprague-DawleyBradykininCalciumEnzyme InhibitorsInositol PhosphatesJA 2 compoundMetalloproteasesOligopeptidesTrpv1 protein, ratTRPV Cation Channels

Identifiers

PMID21458920
PMCPMC3114295
OpenAlexW2015391771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.